Kenvue Inc. Common Stock (KVUE)

These companies lead their respective markets, making them must-haves for buy-and-hold dividend investors.

Activist investor Starboard Value LP has reportedly acquired a 7.7% stake worth approximately $500 million in Qorvo Inc. on Thursday, targeting the struggling semiconductor manufacturer for potential operational changes.

The following 10 one decision stocks have increased their dividends for over 25 years, making them Dividend Aristocrats.

Investing by equal parts in these three dividend stocks produces an average yield of 3%.

Conservative retirement investing is all about creating passive income with quality securities, held for the long-run.

These three dividend-paying companies have all raised their payouts every year for at least 40 consecutive years.

With a solid technical rating of 8 out of 10, KENVUE INC (NYSEKVUE) is showing strong indications of a possible breakout.

The growth rate of the consumer healthcare business could accelerate now that an activist investor is involved.

KVUE earnings call for the period ending September 30, 2024.

FDA proposes removing oral phenylephrine from OTC drugs for nasal congestion, citing ineffectiveness. Public comments open before a final order is issued.

Kenvue reports Q3 sales of $3.89 billion, slightly missing estimates. Strong growth in Essential Health offsets declines in Skin Health and Beauty.

Can tinkering around the edges actually make this stock more attractive?

While tech-based growth stocks might seem like the right play, you can't ignore dividends if you want to have a strong portfolio.

Ken Griffin's Citadel just added 18 million shares of an under-the-radar consumer health stock.

An activist investor is taking a stake in Kenvue stock.

The activist investor says Pfizer has underperformed its peers and the broader market since 2019.